PUNE, India, November 29, 2016 /PRNewswire/ --
According to a new market research report "Immunohistochemistry Market by Product (Antibody, Reagent, Kits, Slide Staining System, Tissue Microarray) Application (Diagnostics (Cancer, Cardiovascular, Diabetes, Autoimmune, Infectious Diseases) & Drug Testing) End User - Global Forecast to 2021", published by MarketsandMarkets, the global market is expected to reach USD 2.12 Billion by 2021 from USD 1.48 Billion in 2016, at a CAGR of 7.3% from 2016 to 2021.
Browse 181 market data Tables and 44 Figures spread through 225 Pages and in-depth TOC on "Immunohistochemistry Market"
Early buyers will receive 10% customization on this report.
Growing prevalence of cancer and rapidly increasing geriatric population across the globe are the major factors driving the growth of the Immunohistochemistry Market. Other important factors driving market growth include increasing healthcare spending and improving healthcare infrastructure resulting in an increase in the number of hospitals and diagnostic laboratories. The growing consolidation, incorporation of nanotechnology in immunohistochemistry, adoption of multiplex arrays, and automation in this market are the key trends in the market. Rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine offer significant growth opportunities for players in the Immunohistochemistry Market.
In this report, the Immunohistochemistry Market is segmented based on product, application, end user, and region. This report also discusses the key market drivers, restraints, opportunities, and challenges for this market and its submarkets.
Download The Free PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=121632939
In 2015, the hospitals and diagnostic laboratories segment accounted for the largest share of Immunohistochemistry Market, by end user. The large share of the hospitals and diagnostic laboratories segment can be attributed to growing use of immunohistochemistry reagents, antibodies, and equipment for diagnostic procedures. Furthermore, technological advancements such as automated sample preparation and digital pathology and its greater utilization in the diagnosis of many chronic and life-threatening diseases are expected to contribute to the growth of this market.
In 2015, the immunohistochemistry antibody segment accounted for the largest share of Immunohistochemistry Market, by product. The large share of the immunohistochemistry antibody segment can be attributed to improved approval rate for therapeutic antibodies by regulatory authorities, increasing adoption of targeted immunotherapy, and increased R&D expenditure of pharmaceutical and biotechnology companies. The increasing risk of infectious diseases and rising demand for immune-therapeutics are expected to further drive market growth for this segment. Moreover, the rising adoption of immunohistochemistry test, high-throughput assays, such as array comparative genomic hybridization, cDNA microarray, next-generation sequencing techniques, and histological tests, have led to the rapid discovery of thousands of potential antibodies.
In 2015, the cancer segment accounted for the largest share of the Immunohistochemistry Market, by application. The large share of diagnostic application in cancer diseases can be attributed to increasing prevalence of cancer, rapidly increasing geriatric population in developed countries, increased awareness and demand for immunohistochemistry in histopathology, and demand for early diagnosis in developing countries in Asia-Pacific and Latin America.
The major players in the Immunohistochemistry Market are F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Merck Millipore (U.S.), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Abcam plc (U.K.), Cell Signaling Technology, Inc. (U.S.), and Bio SB Inc. (U.S.).
Browse Related Reports:
Cancer Diagnostics Market by Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma) - Forecast to 2020.
Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer), Product, and End Users & Region - Global Forecast to 2020.
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Knowledgestore.asp
Contact: Mr. Rohan MarketsandMarkets 701 Pike Street Suite 2175, Seattle WA 98101, United States Telephone No: 1-888-600-6441 Email: firstname.lastname@example.org
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
Subscribe to our Free Newsletters!
This is a branch of telemedicine that delivers eye care via a digital medical equipment and ...
Inborn errors of metabolism are genetic disorders that hamper the body''s metabolism resulting in ...
Neuroblastoma is a very rare type of childhood cancer that develops in immature nerve cells ...View All